C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/42 (2006.01) C07K 16/10 (2006.01) C07K 16/42 (2006.01) C12N 1/21 (2006.01) C12N 15/70 (2006.01) C12N 15/85 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2093099
73/JWW31 18709 TITLE OF INVENTION RECOMBINANT HUMAN HIV-NEUTRALIZING MONOCLONAL ANTIBODIES FOR PREVENTION AND TREATMENT OF HIV INFECTION ABSTRACT OF THE DISCLOSURE Recombinant human immunoglobulin molecules neutralizing for HIV-1, methods of production of the immunoglobulins and methods of preventing HIV-1 infection using the immunoglobulins are disclosed. DNA constructs containing the complementarity determining regions (CDRs) and framework (FRs) of the native human antibody are combined with other constant regions, and expressed in recombinant host cells. These recombinant antibodies are useful for the treatment and prevention of HIV-1 infection in vivo.
Conley Anthony J.
Emini Emilio A.
Johnson L. Syd
Mark George E.
Pfarr David S.
Gowling Lafleur Henderson Llp
Johnson L. Syd
Medimmune Inc.
Merck & Co. Inc.
Pfarr David S.
LandOfFree
Recombinant human hiv-neutralizing monoclonal antibodies for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant human hiv-neutralizing monoclonal antibodies for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant human hiv-neutralizing monoclonal antibodies for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1635659